Grupo Oftalmo-Biología Experimental
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Instituto de Salud Carlos III (8)
2023
-
Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature
European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14
2022
-
CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature
Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475
-
Vogt-Koyanagi-Harada disease in Spain
European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554
2020
-
Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients
PloS one, Vol. 15, Núm. 7, pp. e0236071
-
Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach
European Journal of Ophthalmology, Vol. 30, Núm. 5, pp. 1042-1052
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807